In the present work, an extensive analysis of the Ca2+ entry in CLL cells was performed, revealing, in patients with progressive disease, the implication of a constitutive and BCR-independent Ca2+ entry pathway. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.